Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Benefit of Early versus Deferred Antiretroviral Therapy on Progression of Liver Fibrosis among People with HIV in the START Randomized Trial

Published:2019-02-19 Issue:3 Volume:69 Page:1135-1150
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Dharan Nila J.¹^ORCID,Neuhaus Jacqueline²,Rockstroh Juergen K.³,Peters Lars⁴,Gordin Fred⁵,Arenas-Pinto Alejandro⁶,Emerson Carol⁷,Marks Kristen⁸,Hidalgo Jose⁹,Sarmento-Castro Rui¹⁰,Stephan Christoph¹¹,Kumarasamy Nagalingeswaran¹²,Emery Sean¹¹³,Matthews Gail V.¹,

Affiliation:

1. Kirby Institute; UNSW Sydney; Sydney Australia

2. University of Minnesota; Minneapolis Minnesota United States

3. University Hospital Bonn; Bonn Germany

4. CHIP, Department of Infectious Disease; Rigshospitalet; Copenhagen Denmark

5. VA Medical Center; Washington DC

6. MRC Clinical Trails Unit; University College London; London United Kingdom

7. Belfast Healthcare Trust; Belfast United Kingdom

8. Weill Medical College of Cornell University; New York NY

9. Vía Libre / Guillermo Almenara Hospital; Lima Peru

10. University Hospital of Porto; Porto Portugal

11. Johann Wolfgang Goethe University Hospital; Frankfurt Germany

12. YRGCARE Medical Centre; Voluntary Health Services; Chennai India

13. Faculty of Medicine; University of Queensland; Brisbane Australia

Funder

National Institutes of Health

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/hep.30296/fullpdf

Reference33 articles.

1. Non-alcoholic fatty liver disease in HIV infection;Macias;AIDS Rev,2017

2. Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) in HIV;Rockstroh;Curr HIV/AIDS Rep,2017

3. Factors associated with specific causes of death amongst HIV-positive individuals in the D:A: D Study;Smith;AIDS,2010

4. Alcohol use, viral hepatitis and liver fibrosis among HIV-positive persons in West Africa: a cross-sectional study;Jaquet;J Int AIDS Soc,2017

5. Risk factors for advanced liver fibrosis in HIV-infected individuals: role of antiretroviral drugs and insulin resistance;Blanco;J Viral Hepat,2011

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HIV-HBV Coinfection—Current Challenges for Virologic Monitoring;Biomedicines;2023-04-28

2. Association of Liver Fibrosis Risk Scores with Cardiovascular and All-Cause Mortality in Us General Population: Results from Nhanes 1999–2014;2023

3. Human Immunodeficiency Virus Infection and Acquired Immunodeficiency Syndrome;Clinical Immunology;2023

4. Causes and outcomes of hepatic fibrosis in persons living with HIV;Current Opinion in HIV and AIDS;2022-09-12

5. Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March–December 2020;JAIDS Journal of Acquired Immune Deficiency Syndromes;2022-08-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3